Gefitinib IP 250 mg tablets typically belong to a category of anti-cancer drugs called as tyrosine kinase inhibitor (TKI) and are available as reddish brown color film coated tablets for daily oral administration. The gefitinib tablets ip 250 mg are used for treating patients suffering from a type of cancer named non-small cell lung cancer (NSCLC).
Prior to administration of these tablets, certain lab tests are performed on the cancerous cells derived after a lung biopsy or previous surgeries to verify and check the level of Epidermal Growth Factor Receptor. This is necessary because Gefitinib works only for such cancers that have an abnormal variety of the protein known as EGFR.